Trexquant Investment’s Abivax ABVX Stock Holding History

Trexquant Investment’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-48,749	Closed	-$5.43M	–	1852
2026 Q1	$5.43M	Buy	48,749 +4,981	+11%	+$589K	0.04%	616
2025 Q4	$5.9M	Sell	43,768 -12,652	-22%	-$1.38M	0.05%	515
2025 Q3	$4.79M	Buy	+56,420	New	+$3.46M	0.05%	565

Other funds holding ABVX

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Jupiter Topco New York $245B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Trexquant Investment's ABVX Position: Q2 2026 in Review

Trexquant Investment sold out of Abivax (ABVX) in Q2 2026, closing a stake of 48,749 shares — an estimated $5.43M sold.

Trexquant Investment first reported a position in ABVX in Q3 2025 and held it in 3 quarters. The position peaked at $5.9M in Q4 2025. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

Trexquant Investment reported no remaining Abivax position as of Q2 2026 after selling out during the quarter.
Trexquant Investment sold 48,749 Abivax shares in Q2 2026, an estimated $5.43M.
Trexquant Investment first reported a position in Abivax in Q3 2025 and held it in 3 quarters.
Trexquant Investment's Abivax position peaked at $5.9M in Q4 2025.
304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.